Delivery Order SPE2DB20D3101-SPE2DB25FRLF7
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of LYBALVI 5-10 MG TABLET in quantities of 30, with a ceiling value of $10,663.06. The contract is a Firm Fixed Price arrangement, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,185.87, is for the delivery of the pharmaceutical product LYBALVI 5-10 MG TABLET UU 30S. The contract is a Firm Fixed Price Delivery Order with a completion date of January 6, 2025. There is no set-aside designation indicated for this contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,638.41 firm fixed-price delivery order is for pharmaceutical products, including the drug Lybalvi 5-10 mg tablet, to support military healthcare programs. The contract has an ultimate completion date of July 24, 2024. This is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,175.45, is a delivery order for the pharmaceutical product LYBALVI 10-10 MG TABLET UU 30S. The contract has an ultimate completion date of February 10, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,164.36 and a performance period through May 9, 2025. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management. The contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of various prescription medications and medical supplies. The contract has a firm fixed price of $14,653.20 and a performance period ending on May 14, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The contract has a firm fixed price structure, a ceiling value of $123,044.10, and a performance period through May 2025. It is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price of $90,134.47 and a period of performance through May 12, 2025. Amerisourcebergen will supply a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of pharmaceutical products, including medications across various therapeutic areas such as diabetes, neurology, and pain management. The contract has a ceiling value of $5,386.07 and a period of performance through May 14, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, has a ceiling value of $93,612.85 and a period of performance through May 20, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that provides a comprehensive global pharmaceutical support...